|
| Home : Avista Capital Partners and Nordic Capital to sell Acino, a leader in advanced drug delivery technologies, to ADQ |
|
Sep 16
2021 |
Avista Capital Partners and Nordic Capital to sell Acino, a leader in advanced drug delivery technologies, to ADQ |
|
NEW YORK and ZURICH, Sept. 16, 2021 /PRNewswire/ -- Leading healthcare investors Avista Capital Partners ("Avista Capital") and Nordic Capital (through Nordic Capital CV1) today announced that they have entered into a definitive agreement to sell Acino ("Acino" or "the Company"), a Swiss... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/avista-capital-partners-and-nordic-capital-to-sell-acino-a-leader-in-advanced-drug-delivery-technologies-to-adq-301378297.html |
| |
|
Related News
|
» Coave Therapeutics and Théa Open Innovation sign exclusive licensing, co-development and commercialization agreement for Europe for CTx-PDE6b, a novel gene therapy candidate in retinitis pigmentosa
» Fence goes up around US Capitol, as law enforcement braces for Sept. 18 protest
|
|
|
